Arbutus Biopharma ABUS
NASDAQ ABUS
$4.69 -0.17 (-3.50%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Equity Income (2018 - 2020)

Updated

Arbutus Biopharma (ABUS) recorded Equity Income of -$2.55 million in FY2020, compared with -$22.52 million in FY2019.

Analysis

Arbutus Biopharma (ABUS) Equity Income (2018 - 2020) Analysis & Trends

  • Per Business Quant data, ABUS's Equity Income was -$22.52 million in FY2019 and -$5.56 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -10.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Arbutus Biopharma 960.50 Mn 587.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -2.55 Mn
Dec 31, 2019 -11.03 Mn
Sep 30, 2019 -3.51 Mn
Jun 30, 2019 -3.33 Mn
Mar 31, 2019 -4.65 Mn
Dec 31, 2018 -2.72 Mn
Sep 30, 2018 -2.84 Mn
API Access

Arbutus Biopharma Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ABUS&period=max&api_key=YOUR_API_KEY